Watchlist Price Alert

Lexeo Therapeutics Inc. C... (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

4.63

-0.08 (-1.70%)

At close: May 02, 2025, 3:59 PM

4.78

3.24%

After-hours: May 02, 2025, 05:38 PM EDT

Lexeo Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	531K	37K	85.55K
Cost of Revenue	n/a	n/a	496K	476K	490K	460K	446.06K	446.94K	n/a	n/a	351.3K	6.7K
Gross Profit	n/a	n/a	-496K	-476K	-490K	-460K	-446.06K	-446.94K	n/a	531K	-314.3K	78.85K
Operating Income	-27.38M	-31.54M	-23.55M	-23.29M	-14.97M	-20.27M	-13.97M	-19.29M	-15.2M	-17.48M	-15.31M	-12.52M
Interest Income	1.49M	2.09M	2.35M	1.65M	1.1M	488K	590K	687K	676K	456K	177K	17.28K
Pretax Income	-25.92M	-29.49M	-21.24M	-21.68M	-14.19M	-20.11M	-13.44M	-18.66M	-14.58M	-17.05M	-15.14M	-12.5M
Net Income	-25.92M	-29.49M	-21.24M	-21.68M	-14.19M	-20.11M	-13.44M	-18.66M	-14.58M	-17.05M	-15.14M	-12.5M
Selling & General & Admin	9.02M	8.12M	6.99M	7.55M	6.76M	3.03M	2.74M	2.85M	3.81M	2.65M	3.08M	2.45M
Research & Development	18.37M	23.42M	16.56M	15.74M	8.21M	17.25M	11.24M	16.44M	11.39M	15.36M	12.27M	10.15M
Other Expenses	n/a	n/a	n/a	n/a	6K	n/a	-3K	-4K	n/a	n/a	n/a	n/a
Operating Expenses	27.38M	31.54M	23.55M	23.29M	14.97M	20.27M	13.97M	19.29M	15.2M	18.01M	15.35M	12.6M
Interest Expense	30K	35K	35K	37K	50K	52K	53K	50K	54K	29K	9K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	27.38M	31.54M	23.55M	23.29M	14.97M	20.27M	13.97M	19.29M	15.2M	18.01M	15.35M	12.6M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2
Shares Outstanding (Basic)	33.08M	33.06M	33M	27.98M	53.54M	25.17M	25.17M	25.17M	n/a	25.17M	25.17M	26.65M
Shares Outstanding (Diluted)	33.08M	33.06M	33M	27.98M	53.54M	25.17M	25.17M	25.17M	n/a	25.17M	25.17M	26.65M
EPS (Basic)	-0.82	-0.89	-0.64	-0.77	-0.53	-0.8	-0.53	-0.74	n/a	-0.68	-0.6	-0.47
EPS (Diluted)	-0.82	-0.89	-0.64	-0.77	-0.53	-0.8	-0.53	-0.74	n/a	-0.68	-0.6	-0.47
EBITDA	-25.4M	-28.95M	-23.05M	-21.17M	-13.65M	-19.6M	-13.53M	-18.84M	-14.08M	-16.68M	-15.13M	-12.51M
EBIT	-25.89M	-29.45M	-21.2M	-21.64M	-14.14M	-20.06M	-13.39M	-18.61M	-14.52M	-17.03M	-15.13M	-12.52M
Depreciation & Amortization	521K	509K	496K	476K	490K	460K	446K	447K	445K	342K	n/a	6.7K